Lachlan is the Co-founder and CEO of Replay. He was previously a founding Principal at Oxford Science Enterprises (formerly OSI) where he made seed investments in companies at the intersection of technology and biology including investing the first capital in ONI, OMass Therapeutics, Nucleome Therapeutics, Spybiotech and Base Genomics. Base Genomics was acquired for $410m four months after an $11m seed financing, creating the largest ever IRR for a life sciences deal. He is also a Director of Depixus, a DNA/RNA sequencing company. He has an MA in Chemistry from the University of Oxford.